Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Otezla in Prurigo Nodularis
NCT03576287Phase 2Unknown
- Start
- Jul 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apremilast in prurigo nodularis (PN). Status: unknown.
02
Drugs
apremilast
03
Conditions
prurigo nodularis (PN)
Beyond the preview
Go deeper on NCT03576287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03576287.